Company Filing History:
Years Active: 2014-2017
Title: Yosef Rosenfeld: Innovator in Nucleic Acid Matrix Compositions
Introduction
Yosef Rosenfeld is a notable inventor based in Ness-Ziona, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of sustained-release nucleic acid matrix compositions. With a total of two patents to his name, Rosenfeld's work is paving the way for advancements in controlled release systems for nucleic acid agents.
Latest Patents
Rosenfeld's latest patents focus on compositions for the extended release of nucleic acid agents. The first patent describes a lipid-saturated matrix formed with a biodegradable polymer, which allows for the controlled release of nucleic acid agents. The second patent reiterates the importance of biodegradable polymers in creating effective matrix compositions for sustained release. Both patents provide methods for producing these matrix compositions and highlight their potential applications in various therapeutic contexts.
Career Highlights
Yosef Rosenfeld is currently associated with Polypid Ltd., a company that specializes in innovative drug delivery systems. His work at Polypid Ltd. emphasizes the importance of developing advanced technologies that enhance the efficacy of nucleic acid therapies. Rosenfeld's expertise in this area has positioned him as a key player in the biotechnology sector.
Collaborations
Rosenfeld collaborates with Noam Emanuel, contributing to the innovative projects at Polypid Ltd. Their combined efforts aim to push the boundaries of drug delivery systems and improve patient outcomes.
Conclusion
Yosef Rosenfeld's contributions to the field of biotechnology, particularly through his patents on sustained-release nucleic acid matrix compositions, demonstrate his commitment to innovation. His work continues to influence the development of advanced therapeutic solutions.